Evidence for cross-hemispheric preconditioning in experimental Parkinson’s disease

作者: Justin N. Weilnau , Michael A. Carcella , Kristin M. Miner , Tarun N. Bhatia , Daniel F. Hutchison

DOI: 10.1007/S00429-017-1552-6

关键词: NeuroscienceDopaminergicParkinson's diseaseSubstantia nigraDopaminergic CellNeurodegenerationStriatumPsychologyDopamineNigrostriatal pathway

摘要: Dopamine loss and motor deficits in Parkinson’s disease typically commence unilaterally remain asymmetric for many years, raising the possibility that endogenous defenses slow cross-hemispheric transmission of pathology. It is well-established biological response to subtoxic stress prepares cells survive subsequent toxic challenges, a phenomenon known as preconditioning, tolerance, or adaptation. Here we demonstrate unilateral striatal infusions oxidative toxicant 6-hydroxydopamine (6-OHDA) precondition contralateral nigrostriatal pathway against toxicity second 6-OHDA infusion opposite hemisphere. 6-OHDA-induced dopaminergic terminals striatum was ablated by shown two independent markers phenotype, each measured blinded observers. Similarly, somata substantia nigra also abolished, according measurements. Motor asymmetries floor landings, forelimb contacts with wall, spontaneous turning behavior were consistent these histological observations. Unilateral increased phosphorylation kinase ERK2 expression antioxidant enzyme CuZn superoxide dismutase both striata, our previous mechanistic work showing proteins mediate preconditioning cells. These findings support existence suggest neurons mount impressive natural defenses, despite their reputation being vulnerable injury. If results generalize humans, pathology may progress slowly asymmetrically because exposure disease-precipitating insult induces bilateral upregulation elicits preconditioning.

参考文章(127)
J CANNON, Y HUA, R RICHARDSON, G XI, R KEEP, T SCHALLERT, The effect of thrombin on a 6-hydroxydopamine model of Parkinson's disease depends on timing. Behavioural Brain Research. ,vol. 183, pp. 161- 168 ,(2007) , 10.1016/J.BBR.2007.06.004
Paul M. Carvey, Ashok Punati, Mary B. Newman, Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis Cell Transplantation. ,vol. 15, pp. 239- 250 ,(2006) , 10.3727/000000006783981990
Rehana K. Leak, Anthony K. F. Liou, Michael J. Zigmond, Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning Journal of Neurochemistry. ,vol. 99, pp. 1151- 1163 ,(2006) , 10.1111/J.1471-4159.2006.04149.X
Hirokazu Hara, Tetsuro Kamiya, Tetsuo Adachi, Endoplasmic reticulum stress inducers provide protection against 6-hydroxydopamine-induced cytotoxicity. Neurochemistry International. ,vol. 58, pp. 35- 43 ,(2011) , 10.1016/J.NEUINT.2010.10.006
Simon R.W. Stott, Roger A. Barker, Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease European Journal of Neuroscience. ,vol. 39, pp. 1042- 1056 ,(2014) , 10.1111/EJN.12459
Takaaki Kirino, Yoshihiko Tsujita, Akira Tamura, Induced Tolerance to Ischemia in Gerbil Hippocampal Neurons Journal of Cerebral Blood Flow and Metabolism. ,vol. 11, pp. 299- 307 ,(1991) , 10.1038/JCBFM.1991.62
Sophie Dethy, Nadège Van Blercom, Philippe Damhaut, David Wikler, Jerzy Hildebrand, Serge Goldman, Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism Movement Disorders. ,vol. 13, pp. 275- 280 ,(1998) , 10.1002/MDS.870130213